Opinion
PARP inhibitors: New developments in ovarian cancer treatment
Maturing data from ongoing trials will likely expand the opportunity to use PARP inhibitors for the treatment of ovarian cancer.
Arthur-Quan Tran, MD
Maturing data from ongoing trials will likely expand the opportunity to use PARP inhibitors for the treatment of ovarian cancer.